Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark GlaxoSmithKline Fulston
Mark GlaxoSmithKline Fulston
Enzyme
Biological activity
Biochemistry
Microbiology
Streptomyces
4
Papers
164
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Ansamitocin production processes.
2001
Mark GlaxoSmithKline Fulston
Anna GlaxoSmithKline Stefanska
Jan GlaxoSmithKline Thirkettle
Show All
Source
Cite
Save
Citations (0)
SB-253514 and analogues; novel inhibitors of lipoprotein-associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. I. Fermentation of producing strain, isolation and biological activity
2000
The Journal of Antibiotics
Jan GlaxoSmithKline Thirkettle
Emilio Alvarez
Helen Boyd
Murray Brown
Emilio Diez
Juan Hueso
Steve W Elson
Mark GlaxoSmithKline Fulston
Craig Gershater
Maria Luisa Morata
Paloma Pérez
Sarah J. Ready
José María Sánchez Puelles
Rose M. Sheridan
Anna Stefanskac
Stephen R. Warr
Show All
Source
Cite
Save
Citations (39)
A potent seryl tRNA synthetase inhibitor SB-217452 isolated from a Streptomyces species.
2000
The Journal of Antibiotics
Anna L. Stefanska
Mark GlaxoSmithKline Fulston
Catherine S. V. Houge-Frydrych
Jo J. Jones
Stephen R. Warr
Show All
Source
Cite
Save
Citations (77)
Isolation and structure determination of two novel phenazines from a Streptomyces with inhibitory activity against metallo-enzymes, including metallo-β-lactamase
1995
The Journal of Antibiotics
Martin L. Gilpin
Mark GlaxoSmithKline Fulston
David J. Payne
Rebecca Cramp
Ian Hood
Show All
Source
Cite
Save
Citations (48)
1